LataMed AI Provides Shareholder Update on Forward Stock Split and Mandatory Share Exchange

LataMed AI Corp. (OTC: LMED) provided shareholders with an update on Monday regarding the implementation of its previously announced 5-for-1 forward stock split and the related mandatory share exchange process. As of July 7, 2026, the company has submitted all requested documentation to FINRA, and management anticipates the corporate action may become effective within approximately the next week, subject to FINRA’s review and final processing.

The forward stock split will be implemented in conjunction with the assignment of a new CUSIP number, 21116R404, replacing the current CUSIP upon effectiveness. This change is designed to facilitate the mandatory share exchange process and update the company’s capital structure.

LataMed AI detailed how the exchange will be administered for different types of shareholders. For those holding shares through a brokerage account in “street name,” no action is required, as brokerage firms and custodians are expected to process the exchange automatically through normal securities settlement. Similarly, registered book-entry shareholders whose shares are held directly with the transfer agent will have their accounts updated automatically to reflect the post-split share balance and new CUSIP.

Shareholders holding physical stock certificates are not required to immediately surrender their certificates. However, because the split is tied to a mandatory CUSIP exchange, existing certificates will represent the pre-exchange security. When a certificate is submitted for transfer, sale, or exchange, it will be processed under the new procedures, and the transfer agent will issue the appropriate number of post-split shares under the new CUSIP. Additional instructions for certificate submission will be provided by the transfer agent.

Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We want to ensure that our shareholders clearly understand how the forward stock split and mandatory exchange process will be implemented. While the vast majority of shareholders are expected to have their shares updated automatically through their brokerage accounts or book-entry holdings, we believe it is important to provide clear guidance regarding the process for shareholders holding physical stock certificates.”

Looking ahead, management intends to focus on advancing the company’s telemedicine platform and pursuing licensing and commercialization opportunities for its CardioAI, PulmoAI, and NeuroAI artificial intelligence platforms. Dr. Levy noted, “We believe these initiatives represent important components of our long-term strategy to build an integrated digital healthcare ecosystem throughout Latin America.”

Management believes the forward stock split supports the company’s continued corporate development and broader strategic initiatives while facilitating the new CUSIP and updated capital structure. The company encourages shareholders with questions to contact their brokerage firm or the company’s transfer agent once detailed exchange instructions become available.

For additional information, visit https://latamed.ai or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is LataMed AI Provides Shareholder Update on Forward Stock Split and Mandatory Share Exchange.

The post LataMed AI Provides Shareholder Update on Forward Stock Split and Mandatory Share Exchange appeared first on citybuzz.